ACAD: ACADIA Pharmaceuticals Inc
ACAD exchange rate has changed by -1.22% for today. During the day, the instrument was traded at a low of 20.10 and at a high of 20.54.
Follow ACADIA Pharmaceuticals Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ACAD News
- Will Auvelity Continue to Aid Axsome's Top-Line Growth in Q3?
- Needham Reiterates Buy on Acadia Pharmaceuticals, Maintains $35 Price Target
- UBS Downgrades Acadia Pharmaceuticals to Neutral, Lowers Price Target to $23
- Can Nuplazid and Daybue Strengthen Acadia's Growth Prospects?
- 4 CNS Drug Stocks Worth Watching This World Mental Health Day
- RBC Capital Maintains Outperform on Acadia Pharmaceuticals, Lowers Price Target to $36
- Acadia's Daybue Patent Allowance Extends U.S. Protection to March 2041
- Acadia Pharmaceuticals Announces USPTO Issued Notice Of Allowance For U.S. Patent Application No. 17/590,496, Titled “Methods and Compositions for Treatment of Rett Syndrome.”
- Deutsche Bank Maintains Buy on ACADIA Pharmaceuticals, Lowers Price Target to $31
- ACAD Stock Down 13% as Phase II Alzheimer's Study Misses Primary Goal
- HC Wainwright & Co. Maintains Buy on ACADIA Pharmaceuticals, Lowers Price Target to $33
- Citizens Maintains Market Outperform on ACADIA Pharmaceuticals, Lowers Price Target to $33
- BMO Capital Maintains Outperform on ACADIA Pharmaceuticals, Lowers Price Target to $34
- Needham Maintains Buy on ACADIA Pharmaceuticals, Lowers Price Target to $35
- ACADIA Pharmaceuticals Inc. (ACAD) Discusses Top-Line Phase II Results From RADIANT Study of Remlifanserin in Alzheimer's Disease Psychosis Transcript
- Citigroup Maintains Buy on ACADIA Pharmaceuticals, Lowers Price Target to $33
- Acadia Drug Misses Primary Goal in Alzheimer’s Related Psychosis
- ACADIA Pharmaceuticals Inc. (ACAD) Discusses Top-Line Phase II Results From RADIANT Study of Remlifanserin in Alzheimer's Disease Psychosis - Slideshow (NASDAQ:ACAD) 2026-09-24
- Crude Oil Rises Over 4%; Darden Earnings Miss Views
- Acadia Pharmaceuticals: Remlifanserin Is In Trouble (NASDAQ:ACAD)
- Bears Chase Down Acadia Pharma After Surprise Alzheimer's Setback
- Needham Reiterates Buy on ACADIA Pharmaceuticals, Maintains $41 Price Target
Frequently Asked Questions
What is ACAD stock price today?
ACADIA Pharmaceuticals Inc stock is priced at 20.19 today. It trades within 20.10 - 20.54, yesterday's close was 20.44, and trading volume reached 2454. The live price chart of ACAD shows these updates.
Does ACADIA Pharmaceuticals Inc stock pay dividends?
ACADIA Pharmaceuticals Inc is currently valued at 20.19. Dividend policy depends on the company, while investors also watch -10.27% and USD. View the chart live to track ACAD movements.
How to buy ACAD stock?
You can buy ACADIA Pharmaceuticals Inc shares at the current price of 20.19. Orders are usually placed near 20.19 or 20.49, while 2454 and -1.22% show market activity. Follow ACAD updates on the live chart today.
How to invest into ACAD stock?
Investing in ACADIA Pharmaceuticals Inc involves considering the yearly range 18.39 - 30.96 and current price 20.19. Many compare 1.20% and -9.50% before placing orders at 20.19 or 20.49. Explore the ACAD price chart live with daily changes.
What are ACADIA Pharmaceuticals Inc stock highest prices?
The highest price of ACADIA Pharmaceuticals Inc in the past year was 30.96. Within 18.39 - 30.96, the stock fluctuated notably, and comparing with 20.44 helps spot resistance levels. Track ACADIA Pharmaceuticals Inc performance using the live chart.
What are ACADIA Pharmaceuticals Inc stock lowest prices?
The lowest price of ACADIA Pharmaceuticals Inc (ACAD) over the year was 18.39. Comparing it with the current 20.19 and 18.39 - 30.96 shows potential long-term entry points. Watch ACAD moves on the chart live for more details.
When did ACAD stock split?
ACADIA Pharmaceuticals Inc has gone through stock splits historically. These changes are visible in , 20.44, and -10.27% after corporate actions.
- Previous Close
- 20.44
- Open
- 20.44
- Bid
- 20.19
- Ask
- 20.49
- Low
- 20.10
- High
- 20.54
- Volume
- 2.454 K
- Daily Change
- -1.22%
- Month Change
- 1.20%
- 6 Months Change
- -9.50%
- Year Change
- -10.27%
- Act
- Fcst
- 198 K
- Prev
- 199 K
- Act
- Fcst
- 1.723 M
- Prev
- 1.710 M
- Act
- Fcst
- 0.0%
- Prev
- -0.1%
- Act
- Fcst
- Prev
- 1.955%